AI news impact · China A-shares

GemPharmatech Co., Ltd. Class A (688046) news impact

On 2026-11-12 Wave Radar's AI rated the news on GemPharmatech Co., Ltd. Class A as major positive (impact score +65%).

GemPharmatech reported Q1-Q3 2026 net profit of 170 million yuan (+54.79% YoY) and saw net margin purchases exceeding 10 million yuan.

Direction
Major positive
Impact score
+65%
Confidence
85%
Headlines read
5
Date
2026-11-12
Open 688046 news in Wave Radar

AI assessment

A 54.79% YoY net profit surge in Q1-Q3 demonstrates robust operational profitability and strong growth momentum.

Sector impact

Provides positive earnings sentiment for the laboratory animal models and life sciences tools sector.

Headlines the AI read

Rating history

One rating per trading day the stock was covered.

More on GemPharmatech Co., Ltd. Class A

688046 valuation

How the rating works

After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.